In many Ugandan homes, the birth of a child is a moment of celebration. But for thousands of families each year, that joy is quickly overshadowed by a diagnosis that can shape a child’s entire life.
Across Uganda, about 20,000 babies are born annually with sickle cell disease—a genetic condition that causes severe pain, recurrent infections, and, too often, early death.
For some families, the diagnosis comes too late.
Between 6,000 and 9,000 of these children die before their fifth birthday, largely due to delayed detection and limited access to specialised care. Yet the risk begins long before birth. An estimated 13.3 percent of Ugandans carry the sickle cell trait—roughly one in seven people—often without knowing it.
It is a quiet crisis, unfolding in homes, schools, and hospitals across the country. In March 2026, lawmakers in Parliament sounded the alarm. Led by Asuman Basalirwa, MPs adopted a motion calling for urgent government funding and for sickle cell disease to be prioritised as a major non-communicable disease.
“Despite government efforts, inadequate funding continues to drive high prevalence and preventable deaths,” Basalirwa told the House. The urgency is visible in hospital wards. Admissions linked to sickle cell disease have risen by nearly 30 percent in recent years, placing additional strain on families and an already stretched health system.
But the burden is not only medical. “In many homes, this condition is wrongly blamed on mothers,” Basalirwa said. “That fuels stigma and even domestic violence.”
Children face challenges beyond the clinic. In schools, limited awareness can put lives at risk—simple actions like exposure to cold can trigger life-threatening complications. For some lawmakers, prevention must begin before marriage.
Charles Ayume, a medical doctor, has called for premarital testing to help couples understand their genetic risk. “Sickle cell disease is preventable,” he said. “Couples need to know their status before starting families.”
Treatment options exist, but access remains uneven. Drugs like Hydroxyurea can significantly reduce complications, yet many patients cannot afford or access them consistently.
Government officials say steps are being taken. According to Hamson Obua, new diagnostic machines have been deployed in parts of the country, and sickle cell care is being integrated into the broader health system.
A major shift came in February 2026, when the Ministry of Health Uganda rolled out mandatory newborn screening at public health facilities. The programme aims to detect the disease early, allowing children to receive preventive treatment, vaccinations, and ongoing care. Free testing kits are now being distributed nationwide, offering hope that fewer children will slip through the cracks.
Still, experts warn that policy alone will not be enough. Sustained investment in screening, public awareness, genetic counselling, and treatment access is critical if Uganda is to reduce the heavy toll of the disease.
Back in communities, families continue to navigate the daily realities of sickle cell—hospital visits, school disruptions, and the constant fear of the next crisis. For them, the statistics debated in Parliament are deeply personal.
Uganda now stands at a crossroads: with the right investment and awareness, thousands of young lives could be saved each year. Without it, the cycle of preventable deaths and silent suffering will continue.
